Nasdaq · Consumer Staples
PETMED EXPRESS INC (PETS)
As-reported financials and recent SEC filings for PETMED EXPRESS INC, latest fiscal period FY2026. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$179.0M
Net income
$-57.3M
Net margin
-32.0%
Diluted EPS
$-2.74
ROE
-197.9%
P/E (TTM)
—
Market cap
$37.6M
Debt / equity
—
Income statement (as reported)
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $179.0M | $227.0M | $274.1M | $247.6M | $272.3M |
| Gross profit | — | $69.1M | $84.8M | $76.5M | $76.9M |
| Operating income | $-58.7M | $-1.5M | $-8.2M | $6.1M | $24.3M |
| Net income | $-57.3M | $-6.3M | $-7.5M | $5.1M | $18.7M |
| Diluted EPS | $-2.74 | $-0.30 | $-0.37 | $0.25 | $0.92 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-26
View on EDGAR →8-K2026-06-26
View on EDGAR →DEFA14A2026-06-25
View on EDGAR →DEF 14A2026-06-25
View on EDGAR →42026-06-09
View on EDGAR →10-K2026-06-02
View on EDGAR →8-K2026-06-02
View on EDGAR →8-K2026-05-21
View on EDGAR →Go deeper on PETS
Search PETMED EXPRESS INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.